Table 2 |
||
|
Effects of the treatment on the assessed variables for all participants |
||
|
Δ6 m |
P |
|
|
|
||
|
BMI (kg/m2) |
0.45 ± 0.07 |
0.466 |
|
DAS |
-2.37 ± 0.4 |
0.000 |
|
HAQ |
-0.4 ± 0.01 |
0.001 |
|
ESR (mm/h) |
-18.55 ± 12.8 |
0.002 |
|
CRP (μg/L) |
-16.1 ± 9.4 |
0.016 |
|
HOMA |
-0.2 ± 0.1 |
0.088 |
|
QUICKI |
0.03 ± 0.022 |
0.092 |
|
|
||
|
Δ6 m, mean difference between baseline and six-month measurement; BMI, body mass index; CRP, C-reactive protein; DAS, Disease Activity Score 28; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; HOMA, Homeostasis Model Assessment Of Insulin Resistance; QUICKI, Quantitative Insulin Sensitivity Check Index. |
||
|
Stavropoulos-Kalinoglou et al. Arthritis Research & Therapy 2012 14:R160 doi:10.1186/ar3900 |
||
